Patents by Inventor BRIANA KOZLOWICZ

BRIANA KOZLOWICZ has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11591620
    Abstract: A system for editing of a target sequence at a locus of a host cell is disclosed. The system has a nucleic acid molecule comprising a nucleic acid segment comprising a targeting RNA sequence and an RNA segment that binds a protein. The system also has a nucleic acid molecule comprising a nucleic acid segment encoding a polypeptide with endonuclease activity fused to a protein that binds the RNA segment. The system also comprises a double stranded DNA molecule comprising DNA comprising at least one nucleotide sequence that is capable of binding to the target sequence at the locus.
    Type: Grant
    Filed: May 18, 2018
    Date of Patent: February 28, 2023
    Assignee: CARGILL, INCORPORATED
    Inventors: Kenneth R. Finley, Briana Kozlowicz, Ana Negrete-Raymond, Gregory M. Poynter, Amit Vas
  • Publication number: 20220177926
    Abstract: A system for editing of a target sequence at a locus of a host cell is disclosed. The system has a nucleic acid molecule comprising a nucleic acid segment comprising a targeting RNA sequence and an RNA segment that binds a protein. The system also has a nucleic acid molecule comprising a nucleic acid segment encoding a polypeptide with endonuclease activity fused to a protein that binds the RNA segment. The system also comprises a double stranded DNA molecule comprising DNA comprising at least one nucleotide sequence that is capable of binding to the target sequence at the locus.
    Type: Application
    Filed: May 18, 2018
    Publication date: June 9, 2022
    Applicant: CARGILL, INCORPORATED
    Inventors: Kenneth R. FINLEY, Briana KOZLOWICZ, Ana NEGRETE-RAYMOND, Gregory M. POYNTER, Amit VAS
  • Patent number: 10844363
    Abstract: The present invention relates to a genetically engineered yeast (e.g., Crabtree negative) that express a heterologous xylose isomerase. In a fermentation method the engineered yeast are capable of producing a bioproduct, such as ethanol, in a fermentation medium that includes xylose. Desirable bioproduct titers can be achieved when materials such as acetate are present in the fermentation medium.
    Type: Grant
    Filed: August 4, 2016
    Date of Patent: November 24, 2020
    Assignee: CARGILL, INCORPORATED
    Inventors: Erin Kathleen Marasco, Sara C. McFarlan, Briana Kozlowicz, Chenfeng Lu, Beth M. Mastel
  • Publication number: 20180223271
    Abstract: The present invention relates to a genetically engineered yeast (e.g., Crabtree negative) that express a heterologous xylose isomerase. In a fermentation method the engineered yeast are capable of producing a bioproduct, such as ethanol, in a fermentation medium that includes xylose. Desirable bioproduct titers can be achieved when materials such as acetate are present in the fermentation medium.
    Type: Application
    Filed: August 4, 2016
    Publication date: August 9, 2018
    Inventors: ERIN KATHLEEN MARASCO, SARA C. MCFARLAN, BRIANA KOZLOWICZ, CHENFENG LU, BETH M. MASTEL